Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Roc, L. (Lourdes) | - |
dc.creator | Mendoza, C. (Carmen) de | - |
dc.creator | Fernández-Alonso, M. (Miriam) | - |
dc.creator | Reina, G. (Gabriel) | - |
dc.creator | Soriano, V. (Vincent) | - |
dc.creator | Spanish-HTLV-Network | - |
dc.date.accessioned | 2021-10-27T07:51:29Z | - |
dc.date.available | 2021-10-27T07:51:29Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Roc, L. (Lourdes); de Mendoza, C. (Carmen); Fernández-Alonso, M. (Miriam); et al. "Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals". Therapeutic Advances in Infectious Disease. 6, 2019, 1 - 8 | es_ES |
dc.identifier.issn | 2049-9361 | - |
dc.identifier.uri | https://hdl.handle.net/10171/62284 | - |
dc.description.abstract | Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral therapy. The allograft was removed from the second recipient at month 8 due to rejection and immunosuppressors discontinued. To date, 3 years later, this patient remains infected but asymptomatic. HTLV-1 infection was recognized retrospectively in the donor, a native Spaniard who had sex partners from endemic regions. Our findings call for a reappraisal of screening policies on donor–recipient organ transplantation. Based on the high risk of disease development and the large flux of persons from HTLV-1 endemic regions, pre-transplant HTLV-1 testing should be mandatory in Spain. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | SAGE Publications | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Antiretroviral drugs | es_ES |
dc.subject | HTLV-1 | es_ES |
dc.subject | Myelopathy | es_ES |
dc.subject | Screening | es_ES |
dc.subject | Transplantation | es_ES |
dc.title | Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages. | es_ES |
dc.identifier.doi | 10.1177/2049936119868028 | - |
dadun.citation.endingPage | 8 | es_ES |
dadun.citation.publicationName | Therapeutic Advances in Infectious Disease | es_ES |
dadun.citation.startingPage | 1 | es_ES |
dadun.citation.volume | 6 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.